Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Potentiation of Sulfonylurea Action by an EPAC-selective cAMP Analog in INS-1 Cells: Comparison of Tolbutamide and Gliclazide and a Potential Role for EPAC Activation of a 2-APB-sensitive Ca2+ Influx

Rachel E. Jarrard, Yuchen Wang, Amy E. Salyer, Evan P.S. Pratt, Ian M. Soderling, Marcy L. Guerra, Allison M. Lange, Hilary J. Broderick and Gregory H. Hockerman
Molecular Pharmacology January 2013, 83 (1) 191-205; DOI: https://doi.org/10.1124/mol.112.081943
Rachel E. Jarrard
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuchen Wang
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy E. Salyer
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan P.S. Pratt
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian M. Soderling
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcy L. Guerra
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison M. Lange
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hilary J. Broderick
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory H. Hockerman
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

Tolbutamide and gliclazide block the KATP channel Kir6.2/Sur1, causing membrane depolarization and stimulating insulin secretion in pancreatic beta cells. We examined the ability of the EPAC-selective cAMP analog 8-pCPT-2′-O-Me-cAMP-AM to potentiate the action of these drugs and the mechanism that might account for it. Insulin secretion stimulated by both 200 μM tolbutamide and 20 μM gliclazide, concentrations that had equivalent effects on membrane potential, was inhibited by thapsigargin (1 μM) or the L-type Ca2+ channel blocker nicardipine (2 μM) and was potentiated by 8-pCPT-2′-O-Me-cAMP-AM at concentrations ≥2 μM in INS-1 cells. Ca2+ transients stimulated by either tolbutamide or gliclazide were inhibited by thapsigargin or nicardipine and were significantly potentiated by 8-pCPT-2′-O-Me-cAMP-AM at 5 μM but not 1 μM. Both tolbutamide and gliclazide stimulated phospholipase C activity; however, only gliclazide did so independently of its activity at KATP channels, and this activity was partially inhibited by pertussis toxin. 8-pCPT-2′-O-Me-cAMP-AM alone (5 μM) did not stimulate insulin secretion, but did increase intracellular Ca2+ concentration significantly, and this activity was inhibited by 25 μM 2-aminoethoxydiphenylborate (2-APB) or the removal of extracellular Ca2+. 8-pCPT-2′-O-Me-cAMP-AM potentiation of insulin secretion stimulated by tolbutamide was markedly inhibited by 2-APB (25 μM) and enhanced by the PKC inhibitor bisindolylmaleimide I (1 μM). Our data demonstrate that the actions of both tolbutamide and gliclazide are strongly potentiated by 8-pCPT-2′-O-Me-cAMP-AM, that gliclazide can stimulate phospholipase C activity via a partially pertussis toxin-sensitive mechanism, and that 8-pCPT-2′-O-Me-cAMP-AM potentiation of tolbutamide action may involve activation of a 2-APB-sensitive Ca2+ influx.

Footnotes

  • The work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grant R01 DK064736] to G.H.H.

  • ↵Embedded ImageThis article has supplemental material available at molpharm.aspetjournals.org.

  • dx.doi.org/10.1124/mol.112.081943.

  • Received August 16, 2012.
  • Accepted October 15, 2012.
  • Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 83 (1)
Molecular Pharmacology
Vol. 83, Issue 1
1 Jan 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Potentiation of Sulfonylurea Action by an EPAC-selective cAMP Analog in INS-1 Cells: Comparison of Tolbutamide and Gliclazide and a Potential Role for EPAC Activation of a 2-APB-sensitive Ca2+ Influx
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

EPAC Modulation of Sulfonylurea Action

Rachel E. Jarrard, Yuchen Wang, Amy E. Salyer, Evan P.S. Pratt, Ian M. Soderling, Marcy L. Guerra, Allison M. Lange, Hilary J. Broderick and Gregory H. Hockerman
Molecular Pharmacology January 1, 2013, 83 (1) 191-205; DOI: https://doi.org/10.1124/mol.112.081943

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

EPAC Modulation of Sulfonylurea Action

Rachel E. Jarrard, Yuchen Wang, Amy E. Salyer, Evan P.S. Pratt, Ian M. Soderling, Marcy L. Guerra, Allison M. Lange, Hilary J. Broderick and Gregory H. Hockerman
Molecular Pharmacology January 1, 2013, 83 (1) 191-205; DOI: https://doi.org/10.1124/mol.112.081943
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • GABAAR Molecular Identity in Oligodendrocytes
  • Editing TOP2α Intron-19 5′ SS Circumvents Drug Resistance
  • SerpinA3N and drug induced liver injury
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics